Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1992 2
1993 1
1994 1
1996 2
1998 1
2003 1
2004 1
2005 1
2007 2
2008 4
2009 5
2010 1
2011 6
2012 8
2013 4
2014 8
2015 10
2016 13
2017 5
2018 8
2019 3
2020 4
2021 2
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Electrophysiology Read-Out Tools for Brain-on-Chip Biotechnology.
Forro C, Caron D, Angotzi GN, Gallo V, Berdondini L, Santoro F, Palazzolo G, Panuccio G. Forro C, et al. Among authors: palazzolo g. Micromachines (Basel). 2021 Jan 24;12(2):124. doi: 10.3390/mi12020124. Micromachines (Basel). 2021. PMID: 33498905 Free PMC article. Review.
Treatment of advanced non-small cell lung cancer in the elderly.
Sacco PC, Maione P, Palazzolo G, Gridelli C. Sacco PC, et al. Among authors: palazzolo g. Expert Rev Respir Med. 2018 Sep;12(9):783-792. doi: 10.1080/17476348.2018.1510322. Epub 2018 Aug 21. Expert Rev Respir Med. 2018. PMID: 30092728 Review.
Non-small-cell lung carcinoma vaccines in clinical trials.
Rossi A, Maione P, Schettino C, Bareschino MA, Sacco PC, Ambrosio R, Barbato V, Zeppa R, Palazzolo G, Gridelli C. Rossi A, et al. Among authors: palazzolo g. Expert Rev Vaccines. 2011 Jun;10(6):887-97. doi: 10.1586/erv.11.16. Expert Rev Vaccines. 2011. PMID: 21692707 Review.
The safety of second-line treatment options for non-small cell lung cancer.
Rossi A, Maione P, Santabarbara G, Sacco PC, Casaluce F, Sgambato A, Barzelloni ML, Palazzolo G, Gridelli C. Rossi A, et al. Among authors: palazzolo g. Expert Opin Drug Saf. 2017 Apr;16(4):471-479. doi: 10.1080/14740338.2017.1297795. Epub 2017 Mar 1. Expert Opin Drug Saf. 2017. PMID: 28276858 Review.
Current challenges of lung cancer care in an aging population.
Sacco PC, Casaluce F, Sgambato A, Rossi A, Maione P, Palazzolo G, Napolitano A, Gridelli C. Sacco PC, et al. Among authors: palazzolo g. Expert Rev Anticancer Ther. 2015;15(12):1419-29. doi: 10.1586/14737140.2015.1096201. Epub 2015 Oct 15. Expert Rev Anticancer Ther. 2015. PMID: 26472523 Review.
Emerging drugs targeting PD-1 and PD-L1: reality or hope?
Casaluce F, Sgambato A, Sacco PC, Palazzolo G, Maione P, Rossi A, Ciardiello F, Gridelli C. Casaluce F, et al. Among authors: palazzolo g. Expert Opin Emerg Drugs. 2014 Dec;19(4):557-69. doi: 10.1517/14728214.2014.964682. Epub 2014 Sep 25. Expert Opin Emerg Drugs. 2014. PMID: 25253438 Review.
Optimal drugs for second-line treatment of patients with small-cell lung cancer.
Rossi A, Sacco PC, Sgambato A, Casaluce F, Santabarbara G, Palazzolo G, Maione P, Gridelli C. Rossi A, et al. Among authors: palazzolo g. Expert Opin Pharmacother. 2016;17(7):969-76. doi: 10.1517/14656566.2016.1154539. Epub 2016 Feb 29. Expert Opin Pharmacother. 2016. PMID: 26878692 Review.
93 results